Introduction to FAM86JP (G100125556)

Target Name: FAM86JP

NCBI ID: G100125556

FAM86JP

Other Name(s): family with sequence similarity 86 member J, pseudogene | FAM86JP variant 1 | Family with sequence similarity 86, member A pseudogene, transcript variant 1

Introduction to FAM86JP
FAM86JP, also known as Family with sequence similarity 86, member J, pseudogene, is a recently discovered gene that has gained significant interest as a potential drug target or biomarker in various diseases. This article aims to provide an overview of FAM86JP, its role in disease pathogenesis, and its potential as a therapeutic target or biomarker in medical research and clinical applications.

Discovery and Structure:
FAM86JP is an enigmatic gene that was identified as a pseudogene during the annotation of the human genome. Pseudogenes were initially considered as non-functional genomic relics; however, recent studies have challenged this notion and revealed their involvement in various biological processes. FAM86JP is located on human chromosome 5 and encodes a non-coding RNA molecule.

While the precise function of FAM86JP remains elusive, it has been suggested that it may play a role in regulating gene expression through interaction with protein-coding genes. Further investigations are required to unravel the intricate mechanisms by which FAM86JP exerts its biological effects.

Role in Disease Pathogenesis:
Emerging evidence suggests that FAM86JP may be implicated in the pathogenesis of several diseases. For instance, research has indicated that altered expression of FAM86JP is associated with cancer progression, including gastric, breast, and lung cancer. In these malignancies, FAM86JP expression levels were found to be dysregulated, indicating its potential as a diagnostic or prognostic biomarker.

Additionally, FAM86JP has been linked to neurological disorders such as Alzheimer's disease and schizophrenia. Altered expression levels of FAM86JP were observed in brain tissues of individuals affected by these conditions, suggesting its contribution to their pathogenesis. These findings warrant further investigations to elucidate the precise molecular mechanisms underlying FAM86JP's involvement in disease development and progression.

Potential Therapeutic Target:
Considering its association with diverse diseases, FAM86JP has garnered attention as a potential therapeutic target. Targeted modulation of FAM86JP expression or activity may hold promise in the development of novel treatment strategies. However, due to limited knowledge regarding FAM86JP's exact function, devising therapeutic interventions targeting this gene remains a challenging task.

Novel techniques such as gene-editing tools, including CRISPR-Cas9, may offer opportunities to manipulate FAM86JP expression selectively. Inhibitors targeting FAM86JP-associated signaling pathways or interacting proteins could also be explored as potential therapeutic agents. Further research is required to unravel the complex interplay of FAM86JP with various cellular processes, which could pave the way for effective targeted interventions.

Biomarker Potential:
In addition to its potential as a therapeutic target, FAM86JP holds promise as a biomarker in disease diagnosis, prognosis, and treatment response prediction. A growing body of evidence suggests that altered FAM86JP expression levels may serve as useful markers for disease progression and response to therapy. For instance, in several cancer types, FAM86JP expression levels positively correlate with tumor stage and patient survival, indicating its potential prognostic value.

Furthermore, FAM86JP's expression pattern may aid in distinguishing between different disease subtypes or predicting treatment response. In the context of neurological disorders, identifying FAM86JP expression signatures could facilitate early diagnosis and the development of personalized treatment strategies for affected individuals.

Conclusion:
FAM86JP, despite being classified as a pseudogene, holds immense potential as both a therapeutic target and biomarker in various diseases. Altered expression patterns of FAM86JP have been observed in multiple conditions, including cancer and neurological disorders, suggesting its involvement in disease pathogenesis. Expanding our understanding of FAM86JP's functions and interactions with cellular processes is crucial to harness its full potential for therapeutic interventions and clinical applications. Continued research in this field will undoubtedly shed light on the intricate role of FAM86JP in health and disease, paving the way for improved diagnostic and therapeutic strategies in the future.

Protein Name: Family With Sequence Similarity 86 Member J, Pseudogene

The "FAM86JP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FAM86JP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets